---
title: "Sanbo: Shareholder TBP plans to reduce its holdings by no more than 3% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253798479.md"
description: "Sanbo announced that shareholder TBP 3Doctors Limited plans to reduce its holdings in the company by no more than 6,089,694 shares within three months after the announcement date, starting fifteen trading days from the date of this announcement. Among them, no more than 2,029,898 shares will be reduced through centralized bidding, and no more than 4,059,796 shares will be reduced through block trading"
datetime: "2025-08-20T11:11:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253798479.md)
  - [en](https://longbridge.com/en/news/253798479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253798479.md)
generator: "portal-rs"
---

# Sanbo: Shareholder TBP plans to reduce its holdings by no more than 3% of the company's shares

Sanbo announced that its shareholder TBP 3DoctorsLimited plans to reduce its holdings in the company by no more than 6,089,694 shares within three months after the fifteenth trading day from the date of this announcement, through centralized bidding and block trading. Among them, the reduction through centralized bidding will not exceed 2,029,898 shares, and the reduction through block trading will not exceed 4,059,796 shares

### Related Stocks

- [301293.CN](https://longbridge.com/en/quote/301293.CN.md)

## Related News & Research

- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)
- [Sabre-backed study shows 54% of travelers already use AI for trip planning](https://longbridge.com/en/news/296371843.md)
- [Turner-Wohlsen JV to deliver $100 million Brandywine Conservancy & Museum of Art expansion](https://longbridge.com/en/news/296448283.md)
- [Butler National Wins Three-Year Extension to Manage Kansas Sports Wagering, Retains 90% Revenue Share](https://longbridge.com/en/news/296516585.md)
- [Tvardi Therapeutics: TTI-109 targets STAT3 to address unmet needs in UC with selective immune modulation and safety](https://longbridge.com/en/news/296374826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**